If your patient shows signs of cognitive impairment during a routine visit, Medicare covers a separate visit to more thoroughly assess your patient’s cognitive function and develop a care plan. Use…
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1,…
To enhance efficiency and ensure the secure handling of appeal information, all providers will be required to use SPOT to check appeal status and access duplicate appeal decision letters, effective…